Literature DB >> 30366819

AAV Immunogenicity: New Answers Create New Questions.

Jamie L Shirley1, Roland W Herzog2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30366819      PMCID： PMC6225012          DOI： 10.1016/j.ymthe.2018.10.004

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  4 in total

1.  The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose.

Authors:  Sandeep R P Kumar; Brad E Hoffman; Cox Terhorst; Ype P de Jong; Roland W Herzog
Journal:  Mol Ther       Date:  2017-03-09       Impact factor: 11.454

2.  Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction.

Authors:  Wenwei Shao; Lauriel F Earley; Zheng Chai; Xiaojing Chen; Junjiang Sun; Ting He; Meng Deng; Matthew L Hirsch; Jenny Ting; R Jude Samulski; Chengwen Li
Journal:  JCI Insight       Date:  2018-06-21

3.  Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells.

Authors:  Geoffrey L Rogers; Jamie L Shirley; Irene Zolotukhin; Sandeep R P Kumar; Alexandra Sherman; George Q Perrin; Brad E Hoffman; Arun Srivastava; Etiena Basner-Tschakarjan; Mark A Wallet; Cox Terhorst; Moanaro Biswas; Roland W Herzog
Journal:  Blood       Date:  2017-05-03       Impact factor: 22.113

4.  Exposure to wild-type AAV drives distinct capsid immunity profiles in humans.

Authors:  Klaudia Kuranda; Priscilla Jean-Alphonse; Christian Leborgne; Romain Hardet; Fanny Collaud; Solenne Marmier; Helena Costa Verdera; Giuseppe Ronzitti; Philippe Veron; Federico Mingozzi
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.